{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:19:42Z","timestamp":1740633582071,"version":"3.38.0"},"reference-count":19,"publisher":"Scientific Scholar","content-domain":{"domain":["indianjnephrol.org"],"crossmark-restriction":true},"short-container-title":["Indian J Nephrol"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The COVID-19 pandemic had a major impact on solid organ transplant recipients. COVID-19 vaccination plays a crucial role in pandemic management.There is limited data on replication-defective viral vectors [ChAdOx1-nCOV (COVISHIELD<jats:sup>TM<\/jats:sup>)] and whole inactivated one BBV-152 (COVAXIN<jats:sup>TM<\/jats:sup>) in kidney transplant recipients (KTRs). This study aims to assess the humoral immune response and adverse effects of these vaccines in KTRs after the first and second doses of vaccination.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods<\/jats:title>\n<jats:p>Anti-SARS-CoV-2 anti-spike antibody titers were measured in 285 KTRs recipients prior to vaccination, 3 weeks \u00b1 3 days after first dose and 3 weeks \u00b1 3 days after second dose of the COVISHIELD (n = 232) and COVAXIN (n = 55) vaccines. Anti-spike antibodies were measured by the chemiluminescence immunoassay method. The primary outcome was seroconversion after two doses of COVAXIN and COVISHIELD and secondary outcome was the incidence of adverse events to COVID-19 vaccines within one week of vaccination.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>At baseline, 25 (39.7%) and 67 (30.2%) of KTRs were found to be seropositive before receiving COVAXIN<jats:sup>TM<\/jats:sup> and COVISHIELD<jats:sup>TM<\/jats:sup>, respectively. After first dose of vaccination, 46 (73.0%) and 158 (71.2%) were seropositive and after second dose, 51 (81.0%) and 177 (79.7%) were seropositive, respectively. Common adverse effects were fever, chills, myalgia, and headache which settled in 1\u20132 days. There was no episode of rejection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Both ChAdOx1-nCOV and BBV-152 were well tolerated and induced robust antibody formation in KTRs in the Indian population.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijn_549_23","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T09:57:08Z","timestamp":1722506228000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibody Response to Covishield and Covaxin in Kidney Transplant Recipients"],"prefix":"10.25259","volume":"35","author":[{"given":"Neha","family":"Manhas","sequence":"first","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam Bihari","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit Kumar","family":"Mahapatra","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhyudaysingh","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidharth Kumar","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Kidney Transplantation, Medanta Institute of Kidney and Urology, Medanta-The Medicity, Gurugram, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"10.25259\/ijn_549_23\/ref-1","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1111\/ajt.16261","article-title":"Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients","volume":"20","author":"Hartzell","year":"2020","journal-title":"Am J Transplant."},{"key":"10.25259\/ijn_549_23\/ref-3","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1016\/j.vaccine.2021.09.055","article-title":"Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM\u00ae) and BBV-152 (CovaxinTM\u00ae) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study","volume":"39","author":"Singh","year":"2021","journal-title":"Vaccine"},{"key":"10.25259\/ijn_549_23\/ref-4","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.transproceed.2020.07.002","article-title":"Early report on published outcomes in kidney transplant recipients compared to nontransplant patients infected with coronavirus disease 2019","volume":"52","author":"Aziz","year":"2020","journal-title":"Transplant Proc"},{"key":"10.25259\/ijn_549_23\/ref-5","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.kint.2020.08.005","article-title":"An initial report from the French SOT COVID registry suggests high mortality due to COVID-19 in recipients of kidney transplants","volume":"98","author":"Caillard","year":"2020","journal-title":"Kidney int"},{"key":"10.25259\/ijn_549_23\/ref-6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/ajt.16424","article-title":"Is COVID-19 infection more severe in kidney transplant recipients","volume":"21","author":"Caillard","year":"2021","journal-title":"Am J Transplant"},{"key":"10.25259\/ijn_549_23\/ref-8","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.2021.4385","article-title":"Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"Jama"},{"key":"10.25259\/ijn_549_23\/ref-9","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"Jama"},{"key":"10.25259\/ijn_549_23\/ref-10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41581-021-00491-7","article-title":"COVID-19 vaccination in kidney transplant recipients","volume":"17","author":"Caillard","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.25259\/ijn_549_23\/ref-11","doi-asserted-by":"publisher","first-page":"911738","DOI":"10.3389\/fimmu.2022.911738","article-title":"Seroconversion rate after SARS-CoV-2 infection and two doses of either ChAdOx1-nCOV COVISHIELD\u2122 or BBV-152 COVAXIN\u2122 vaccination in renal allograft recipients: An experience of two public and private tertiary care centre","volume":"13","author":"Prasad","year":"2022","journal-title":"Front Immunol"},{"key":"10.25259\/ijn_549_23\/ref-12","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3390\/vaccines10101693","article-title":"Antibody response to ChAdOx1 nCoV-19 (AZD1222) vaccine in kidney transplant recipients","volume":"10","author":"Bhadauria","year":"2022","journal-title":"Vaccines"},{"key":"10.25259\/ijn_549_23\/ref-13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/ckj\/sfac057","article-title":"Post-vaccination analysis of anti-spike antibody responses in kidney transplant recipients with and without COVID-19 infection in a tertiary care centre, India","volume":"15","author":"Jasuja","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.25259\/ijn_549_23\/ref-14","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"The Lancet"},{"key":"10.25259\/ijn_549_23\/ref-15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation","volume":"13","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"key":"10.25259\/ijn_549_23\/ref-16","first-page":"411","article-title":"Safety and antibody response to BNT162b2 and ChAdOx1 nCoV-19 vaccines in kidney transplant recipients","volume":"5","author":"AlShaqaq","year":"2021","journal-title":"J. Environ. Sci Pub Health"},{"key":"10.25259\/ijn_549_23\/ref-17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.kint.2021.03.014","article-title":"Weak anti\u2013SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients","volume":"99","author":"Benotmane","year":"2021","journal-title":"Kidney int"},{"key":"10.25259\/ijn_549_23\/ref-18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1681\/ASN.2021040480","article-title":"Antibody and T cell response to SARSCoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients","volume":"32","author":"Bertrand","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/ijn_549_23\/ref-19","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1097\/TP.0000000000003764","article-title":"Kidney transplant recipients rarely show an early antibody response following the first COVID-19 vaccine administration","volume":"105","author":"Stephanie","year":"2021","journal-title":"Transplantation"},{"key":"10.25259\/ijn_549_23\/ref-20","doi-asserted-by":"publisher","first-page":"e24753","DOI":"10.7759\/cureus.24753","article-title":"Safety and efficacy of the COVID19 vaccine in kidney transplant recipients","volume":"14","author":"Altheaby","year":"2022","journal-title":"Cureus"},{"key":"10.25259\/ijn_549_23\/ref-22","doi-asserted-by":"publisher","first-page":"e0245424","DOI":"10.1371\/journal.pone.0245424","article-title":"Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients","volume":"16","author":"Frasca","year":"2021","journal-title":"PLoS One"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/indianjnephrol.org\/antibody-response-to-covishield-and-covaxin-in-kidney-transplant-recipients\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/indianjnephrol.org\/antibody-response-to-covishield-and-covaxin-in-kidney-transplant-recipients\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:34:46Z","timestamp":1740566086000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/antibody-response-to-covishield-and-covaxin-in-kidney-transplant-recipients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":19,"alternative-id":["10.25259\/ijn_549_23"],"URL":"https:\/\/doi.org\/10.25259\/ijn_549_23","relation":{},"ISSN":["1998-3662","0971-4065"],"issn-type":[{"type":"electronic","value":"1998-3662"},{"type":"print","value":"0971-4065"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"article-number":"277"}}